Welcome to narcononcenter.com


Program Information | Locations | Drug Education | Research | Credentials | Contact Us

Narconon Book Store | | News | | Photos | | Stories | | Links | About Us

visit solveaddiction.com to get your copy of Helping Someone Overcome Addiction
If you would like information regarding addiction or assistance in finding treatment, fill in the information below and one of our addiction specialists will contact you with the help you need.

Your First Name

Your Last Name

What would you like help with?

Your Email Address

Your Phone Number

Your Address

City

State

Zip Code

  
 
A Review of Scientific Literature Supporting the Detoxification Method Developed by L. Ron Hubbard.


Compiled August, 1991 by the Foundation for Advancements in Science and Education.


REFERENCES

1. Stanley JS (1986) Broad Scan Analysis of Human Adipose Tissue; Volume 1: Executive Summary EPA 560/5-86-035

2. Axelrod J, Brady RO, Witkop B and Evarts EV (1957) The distribution and metabolism of lysergic acid diethylamide. Ann NY Acad Sci 66:435-444

3. Stolman A (1974) The absorption, distribution, and excretion of drugs and poisons and their metabolites. ln:.Progress in Chem Tox, Vol. 5, A Stolman, ed., Academic Press, pp 1-99

4. James SH and Schnoll SH (1976) Phencyclidine: Tissue distribution in the rat. Clin Tox 9:573-582

5. Nayak PK, Misra AL and Mule SJ (1976) Physiological disposition and biotransformation of [3H]cocaine in acutely and chronically treated rats. J Pharmacol & Exper Ther 196:556-569

6. Rodger L Foltz, Ph.D., Personal communication

7. Friedman H, Ochs HR. Greenblatt DJ and Shader RI (1985) Tissue distribution of diazepam and its metabolite desmethyldiazepam: A human autopsy study. J Clin Pharmacol 25:613-615

8. Dackis CA, Pottash ALC, Annitto W and Gold MS (1982) Persistence of urinary marijuana levels after supervised abstinence. Am J Psychiatry.139:1196-1198

9. Martin BR (1982) Long-term disposition of phencyclidine In mice. Drug Metabolism and Disposition 10:189-193

10. Weiss RD (1988) Protracted elimination of cocaine metabolites In long-term, high-dose cocaine abusers. Amer J Med 85:879-880

11 Cone EJ and Weddington Jr. WW (1989) Prolonged occurrence of cocaine in human saliva and urine after chronic use. J Analytical Toxicol 13:65-68

12. Ramazzini, B (1713) Diseases of Workers, New York Academy of Medicine, History of Medicine Series, Vol. 23, Hafner Publishing Co., New York, 1964

13. Guzelian PS (1982) Chlordecone poisoning: A case study in approaches of detoxification of humans exposed to environmental chemicals. Drug Metab Reviews13:663-679

14. Ricks A et al. (1989) The Radiological Accident In Golania, Unipub Publications, Lanham, MD. (Reported by Hixson JR in Medical Tribune, Thursday, September 22, 1988)

15. Imamura M, Tung T-C (1984) A trial of fasting cure for PCB poisoned patients in Taiwan. Am J Ind Med 5:147-153

16. Chisolm Jr. JJ (1968) The use of chelating agents in the treatment of acute and chronic lead intoxication In childhood. J Pediatrics 73:1-38

17. Wedeen RP, Batuman V and Landy E (1983) The safety of the EDTA lead-mobilization test. Env Research 30:58-62

18. Bulow J (1983) Adipose tissue blood flow during exercise. Danish Medical Bulletin 30(2) :85-100

19. Frledberg SJ, Harlan Jr. WR, Trout DL. Estes Jr. EH (1960) The effect of exercise on the concentration and turnover of plasma nonesterified fatty acids. J Clin Invest 39:215

20. Carlson LA and Pernow B (1961) Studies on blood lipids during exercise. J Lab and Clin Med 58:673-681

21. Friedberg SJ, Sher PB, Bogdonoff MD and Estes Jr. EH (1963) The dynamics of plasma free fatty acid metabolism during exercise. J Lipid Research 4:34-38

22. Horstman D, Mendez J, Buskirk ER, Boileau R and Nicholas WS (1971) Lipid metabolism during heavy and moderate exercise. Med and Sci in Sports .3:18-23

23. Taylor AW, Shoemann OW, Lovlin R and Lee S (1971) Plasma free fatty acid mobilizatlon with graded exercise. J Sports Med 11:234-240

24. Wirth A. Schlierf G and Schetler G (1979) Physical activity and lipid metabolism. Klin Wochenshri 57:1195

25. Findlay GM and de Freitas ASW (1971) DDT movement from adipocyte to muscle cell during lipid utilization. Nature 229:63

26. de Freitas AS and Norstrom RJ (1974) Turnover and metabolism of polychlorinated biphenyls in relation to their chemical structure and the movement of lipids In the pigeon. Can J Physiol Pharmacal 52:1081-1094

27. Mitjavila 5, Carrera G and Fernandez Y (1981) Il. Evaluation of the toxic risk of accumulated DOT in the rat: During fat mobilization. Arch Environ Contam Toxicol 10:471-481

28. Seba DB (1990) Thermal chamber depuration: A perspective on man in the sauna. Clinical Ecology 7:1 -12

29. Henderson OL and Wilson BK (1973) Excretion of methadone and metabolites in human sweat. Res Comm Chem Path & Pharmac 5:1-8

30. Vree TB, Muskens ATJM, and Van Possum JM (1972) Excretion of amphetamines in human sweat. Arch Int Pharmacodyn 199:311-317

31. Ishlyama I, Nagai T, Nagal T, Komuro E, Momose T and Akimori N (1979) The significance of drug analysis of sweat in respect to rapid screening for drug abuse. Z Rechtsmed 82:251-256

32. Sunderman Jr. FW, Hohnadel DC, Evenson MA, Wannamaker BB and DahI DS (1974) Excretion of copper in sweat of patients with Wilson's disease during sauna bathing. Ann Clinic Lab Sci 4:407

33. Stopford W (1979) Industrial exposure to mercury. In: The biogeochemistry of mercury in the environment, Elsevier/North-Holland Biomedical Press, pp 367-397

34. Hohnadel DC, Sunderman FW, Nechay MW and McNeely MD (1973) Atomic absorption spectrometry of nickel, copper, zinc, and lead in sweat collected from healthy subjects during sauna bathing. Clinical Chemistry 19:1288-1292

35. Abe T, Mayuzumi J, Kikuchi, Arai S (1980) Seasonal variations In skin temperature, skin pH, evaporative water loss and skin surface lipid values on human skin. Chem Pharm Bull 28:387-392

36. Kimbrough RD (1974) The toxicity of polychlorinated polycyclic compounds and related chemicals. CRC Critical Rev Toxicol 2:445-499

37. Kimbrough RD (1980) Occupational exposure. In: Halogenated biphenvls. terphenyls, naphthalenes. dibenzodioxins and related products, Kimbrough RD, ed., Elsevier/North-Holland Biomedical Press, Amsterdam, pp 373-399

38. Tretjak Z, Shields M and Beckmann SL (1990) PCB reduction and clinical improvement by detoxification: An unexploited approach? Human and Experimental Toxicology 9:235-244

39. Carlson LA (1970) Nicotinic acid: its metabolism and its effects on plasma free fatty acids. In: Metabolic Effects of Nicotinic Acid and Its Derivatives, Gey KF and Carl-son LA, eds., Hans Huber, Switzerland, pp 157-165

40. Carlson LA, Oro L and Ostman J (1968) Effect of a single dose of nicotinic acid on plasma lipids In patients with hyperlipoproteinemia. Acta med scand 183:457-465

41. Nye ER and Buchanon B (1969) Short-term effect of nicotinic acid on plasma level and turnover of free fatty acids in sheep and man. J Lipid Research 10:193-196

42. Smith RL (1973) Implications of Biliary Excretion (Chapter 8), In: The Excretory Function of Bile, Chapman and Hail, Ltd., London

43. Parker RJ, Hirom PC and Miliburn P (1980) Enterohepatlc recycling of phenolphthalein,, morphine, lysergic acid diethylamide (LSD) and diphenylacetic acid In the rat. Hydrolysis of glucuronic acid conjugates in the gut lumen. Xenobiotica 10:689-703

44. Moore RB, Anderson JT, Taylor HL, Keys A and Frantz ID (1968) Effect of dietary fat on the fecal excretion of cholesterol and its degradation products in man. J Clinical investigation 47:1517-1534

45. Shepherd J, Stewart JM, Clark JG and Carr K (1980) Sequential changes In plasma lipoproteins and body fat composition during polyunsaturated fat feeding in man. Br J Nutr 44:265-271

46. Bonjour JP (1980) Vitamins and Alcoholism. Internat J Vit Nutr Res 50:215-230;307-338 51:166-177

47. Russell AM (1980) Vitamin A and zinc metabolism in alcoholism. Am J Clin Nut33:2741-2749

48. Roe, DA (1984) Nutrient and drug interactions Nutrition RevIews 42:141 -154

49. Innami S, Nakamura A, Miyazaki M, Nagayarna S and Nishide E (1977) Further studies on the reduction of vitamin A content in the livers of rats given polychlorinated biphenyls. J Nutr Sci Vitaminol 22:409-418

50 Kato N, Kato M, Kirnura T and Yoshida A (1978) Effect of dietary addition of PCB, DDT or HGT and dietary protein on vitamin A and cholesterol metabolism. Nutr Rep Int 18:437-445

51. BrIn M and Roe 0 (1979) Drug-diet Interactions. J FIorida M A 66:424-428

52. Schnare DW, Denk G, Shields M and Brunton S (1982) Evaluation of a detoxification regimen for fat stored xenobiotics. Med Hyp 9:265-282

53. Schnare DW and Robinson PC (1986) Reduction of human body burdens of hexachlorobenzene and polychlorinated biphenyls. In Hexachlorobenzene: Proceedings of an International Symposium, CR Morris and JRP Cabral, eds., International Agency for Research on Cancer, Lyon, France, pp 597-603

54. Roehm D (1983) Effects of a program of sauna baths and megavitamins on adipose DDE and POBs and on clearing of symptoms of Agent Orange (dioxin) toxicity. Clin Res 31(2):243a

55. Schnare DW, Ben M and Shields MG (1984) Body burden reductions of PCBs, PBBs and chlorinated pesticides In human subjects. Ambio. 13:378-380

56. Wolff MS, Anderson HA and Selikoff IJ (1982) Human tissue burdens of halogenated aromatic chemicals in Michigan. JAMA247:2112-2116

57, Tretjak Z. Beckmann S, Tretjak A and Gunnerson C (1989) Occupational, environmental, and public health in Semic: A case study of polychlorinated biphenyl (PCB) pollution. In Post-Audits Projects of Environmental Programs, C Gunnerson, ed., ASCE, New York, NY, pp 57-72

58. Tretjak 7, Root DE, Tretjak A, Slivnik R, Edmorndson E, Graves R and Beckmann SL (1990) Xenobiotic reduction and clinical improvements in capacitor workers: A feasible method. J Env Sci and HealthA25:731-751

59. Root DE and Lionelli GT (1987) Excretion of a lipophilic toxicant through the sebaceous glands: A case report. J Toxicol - Cut & Ocular Toxicol 6:13-17

60. Kilburn KH, Warsaw RH and Shields MG (1989) Neurobehavioral dysfunction in firemen exposed to polychlorinated biphenyls (PCBs): Possible Improvement after detoxification. Arch Env Health 44:345-350

61. Shields M, Beckmann SL and Cassidy-Brinn G (1989) Improvement In perception of transcutaneous nerve stimulation following detoxification In firefighters exposed to PCBs, PCDDs and PCDFs. Clinical Ecology 6:47-50

62. Root DE. Katzin OB. Schnare DW (1985) Diagnosis and treatment of patients presenting subclinical signs and symptoms of exposure to chemicals which bioaccumulate in human tissue. In: Proceedings of the National Conference on Hazardous Wastes and Environmental Emergencies, May 14-16


» Table of contents


Home | Program Information | Drug Education | Locations | Research | Contact Us
Credentials |News | Photos | Stories | Links | Narconon International | About Us
 

 

© 2002 Narconon of Oklahoma, Inc. All rights reserved. NARCONON and the Narconon logo are trademarks and service marks owned by Association for Better Living and Education International and are used with its permission.